Integrating China in the International Consortium for Personalized Medicine Project: Working Groups

Integrating China in the International Consortium for Personalized Medicine (IC2PerMed) project aims to support European Union (EU)-China collaboration over the developments of personalized medicine research, innovations, and policies through the International Consortium for Personalized Medicine (ICPerMed) initiative, providing people with access to personalized, smart, and inclusive healthcare solutions in the near future.

Three Working Groups support the IC2PerMed project. These Working Groups are composed of experts balanced between EU and Chinese stakeholders and genders.

The first Working Group’s activities focus on the awareness and empowerment of citizens and patients, the education and curricula of healthcare professionals, and healthcare sustainability.

The second Working Group’s activities focus on Big Data and ICT solutions and bringing innovation to market.

The third Working Group’s activities focus on translating basic clinical research and beyond and on research funding.

These Working Groups work together to reach the IC2PerMed project’s core objectives.

WFPHA is one of the key partners in the IC2PerMed project.